Minority Views
[To accompany H.R. 3887]
The Committee on Energy and Commerce, to whom was referred
the bill (H.R. 3887) to amend title III of the Public Health
Service Act to reauthorize the program of payments to
children's hospitals that operate graduate medical education
programs, and for other purposes, having considered the same,
reports favorably thereon with an amendment and recommends that
the bill as amended do pass.
CONTENTS
Page
Purpose and Summary.............................................. 3
Background and Need for Legislation.............................. 3
Committee Action................................................. 4
Committee Votes.................................................. 4
Oversight Findings and Recommendations........................... 6
New Budget Authority, Entitlement Authority, and Tax Expenditures 6
Congressional Budget Office Estimate............................. 6
Federal Mandates Statement....................................... 6
Statement of General Performance Goals and Objectives............ 6
Duplication of Federal Programs.................................. 6
Related Committee and Subcommittee Hearings...................... 6
Committee Cost Estimate.......................................... 7
Earmarks, Limited Tax Benefits, and Limited Tariff Benefits...... 7
Advisory Committee Statement..................................... 7
Applicability to Legislative Branch.............................. 7
Section-by-Section Analysis of the Legislation................... 7
Changes in Existing Law Made by the Bill, as Reported............ 7
Minority Views................................................... 17
The amendment is as follows:
Strike all after the enacting clause and insert the
following:
SECTION 1. SHORT TITLE.
This Act may be cited as the ``Children's Hospital GME Support
Reauthorization Act of 2023''.
SEC. 2. PROGRAM OF PAYMENTS TO CHILDREN'S HOSPITALS THAT OPERATE
GRADUATE MEDICAL EDUCATION PROGRAMS.
Section 340E of the Public Health Service Act (42 U.S.C. 256e) is
amended--
(1) in subsection (a), by striking ``2023'' and inserting
``2028'';
(2) in subsection (b)(3)(D), by inserting ``and the end of
fiscal year 2028,'' after ``fiscal year 2022,'';
(3) in subsection (e), by adding at the end the following new
paragraph:
``(4) Prohibition on payments to hospitals furnishing
specified procedures and drugs to minors.--
``(A) In general.--Notwithstanding any other
provision of this section, no payment may be made under
this section to a children's hospital for a fiscal year
(beginning with fiscal year 2024) if, at any point
during the preceding fiscal year, such hospital
furnished specified procedures and drugs (as defined in
subsection (g)) to an individual under 18 years of age.
``(B) Special rule for fiscal year 2024.--In applying
subparagraph (A) with respect to payments described in
such subparagraph for fiscal year 2024--
``(i) the reference to `for a fiscal year'
shall be treated as a reference to `for any
portion of fiscal year 2024 occurring after
December 31, 2023'; and
``(ii) the reference to `the preceding fiscal
year' shall be treated as a reference to `the
period beginning on September 1, 2023, and
ending on December 31, 2023'.
``(C) Rule of construction.--Nothing in this
paragraph shall be construed as prohibiting payments
for a fiscal year (or, in the case of payments for
fiscal year 2024, during the portion of such fiscal
year described in subparagraph (B)(i)) to a hospital
that, during the preceding fiscal year (or, in the case
of payments for fiscal year 2024, during the period
described in subparagraph (B)(ii)), furnished mental or
behavioral health services to individuals under 18
years of age for the treatment of gender dysphoria not
consisting of specified procedures and drugs.'';
(4) in subsection (f)--
(A) in paragraph (1)(A)--
(i) in clause (v), by striking ``and'' at the
end;
(ii) in clause (vi), by striking the period
at the end and inserting ``; and''; and
(iii) by adding at the end the following:
``(vii) for each of fiscal years 2024 through
2028, $124,000,000.''; and
(B) in paragraph (2)--
(i) in subparagraph (E), by striking ``and''
at the end;
(ii) in subparagraph (F), by striking the
period at the end and inserting ``; and''; and
(iii) by adding at the end the following:
``(G) for each of fiscal years 2024 through 2028,
$261,000,000.''; and
(5) in subsection (g), by adding at the end the following new
paragraph:
``(4) Specified procedures and drugs.--
``(A) In general.--Except as provided in subparagraph
(B), the term `specified procedures and drugs' means,
with respect to an individual, any of the following:
``(i) Performing any surgery for the purpose
of changing the body of such individual to
correspond to a sex that differs from their
biological sex, including--
``(I) castration;
``(II) orchiectomy;
``(III) scrotoplasty;
``(IV) vasectomy;
``(V) hysterectomy;
``(VI) oophorectomy;
``(VII) ovariectomy;
``(VIII) metoidioplasty;
``(IX) penectomy;
``(X) phalloplasty;
``(XI) vaginoplasty;
``(XII) vaginectomy;
``(XIII) vulvoplasty;
``(XIV) reduction thyrochondroplasty;
``(XV) chondrolaryngoplasty; and
``(XVI) mastectomy.
``(ii) Any plastic surgery that feminizes or
masculinizes the facial features for the
purposes described in clause (i).
``(iii) Any placement of chest implants to
create feminine breasts for the purposes
described in clause (i).
``(iv) Any placement of fat or artificial
implants in the gluteal region for the purposes
described in clause (i).
``(v) Administering, supplying, prescribing,
dispensing, distributing, or otherwise
conveying to an individual medications for the
purposes described in clause (i), including--
``(I) gonadotropin-releasing hormone
(GnRH) analogues or other puberty-
blocking drugs to stop or delay normal
puberty;
``(II) testosterone or other
androgens to biological females at
doses that are supraphysiologic to the
female sex; and
``(III) estrogen to biological males
at doses that are supraphysiologic to
the male sex.
``(B) Exception.--Subparagraph (A) shall not apply to
the following individuals:
``(i) An individual with both ovarian and
testicular tissue.
``(ii) An individual with respect to whom a
physician has determined through genetic or
biochemical testing that the individual does
not have normal sex chromosome structure, sex
steroid hormone production, or sex steroid
hormone action.
``(iii) An individual experiencing infection,
disease, injury, or disorder caused or
exacerbated by previous medical procedures as
defined in subsection (g)(4)(A).
``(iv) An individual suffering from a
physical disorder, physical injury, or physical
illness that would, as certified by a
physician, place the individual in imminent
danger of death or impairment of a major bodily
function unless the procedure is performed.
``(C) Biological sex.--For purposes of subparagraph
(A), the term `biological sex' means the indication of
male or female sex by reproductive potential or
capacity, sex chromosomes, naturally occurring sex
hormones, gonads, or internal or external genitalia
present at birth.''.
Purpose and Summary
H.R. 3887 reauthorizes payments to children's hospitals
that operate Graduate Medical Education programs for fiscal
years 2024 through 2028. Additionally, the bill prohibits
payments to children's hospitals that furnish specified
procedures or drugs for minors.
Background and Need for Legislation
The Children's Hospitals Graduate Medical Education Program
(CHGME) funds 59 children's hospitals in 30 states and Puerto
Rico to help their graduate medical education (GME) programs
train resident physicians and dentists.\1\ According to the
Health Resources and Services Administration (HRSA), the CHGME
program trains 56 percent of all general pediatrics residents
and 54 percent of all pediatric subspecialty residents and
fellows. HRSA found that the national pediatrician supply is
estimated to grow by 9 percent by 2025, while the demand is
estimated to grow by 6 percent.\2\ Reauthorizing the CHGME
program will help ensure there is a sufficient supply of
pediatricians to meet the expected growth in demand.
---------------------------------------------------------------------------
\1\Health Resources and Services Administration, Children's
Hospitals Graduate Medical Education (CHGME) Payment Program, March
2023.
\2\Ibid.
---------------------------------------------------------------------------
Nearly 18,000 U.S. minors began taking puberty blockers or
hormones from 2017 to 2021.\3\ The number of clinics in the
U.S. focused on providing hormones and surgeries has grown from
just a few to more than 100 in February 2023.\4\ Recent studies
have found that the risk of puberty blockers and hormone
treatment for the purposes of gender transition in minors
currently outweigh the benefits.\5\ Additionally, these
treatments are potentially fraught with irreversible
consequences like cardiovascular disease, osteoporosis,
infertility, increased cancer risk, and thrombosis.\6\
---------------------------------------------------------------------------
\3\British Medical Journal, Gender Dysphoria is Rising and so is
Professional Disagreement, February 23, 2023.
\4\Ibid.
\5\National Board of Health and Welfare, Updated Recommendations
for Hormone Therapy for Gender Dysphoria in Young People, February 22,
2022.
\6\Swedish Agency for Health Technology Assessment and Assessment
of Social Services, Gender Dysphoria in Children and Adolescents: An
Inventory of the Literature, December 20, 2019.
---------------------------------------------------------------------------
Committee Action
On June 14, 2023, the Subcommittee on Health held a hearing
on H.R. 3887. The title of the hearing was ``Examining
Proposals that Provide Access to Care for Patients and Support
Research for Rare Diseases.'' The Subcommittee received
testimony from:
Elizabeth Cherot, MD, MBA, Senior Vice
President and Chief Medical Health Officer, March of
Dimes;
Alexis A. Thompson, MD, MPH, Chief of
Division of Hematology, Elias Schwartz MD Endowed Chair
in Hematology, Children's Hospital of Philadelphia,
Professor of Pediatrics, University of Pennsylvania
Perelman School of Medicine;
Meredithe McNamara, MD, MS, FAAP, Assistant
Professor, Yale School of Medicine;
Miriam Grossman, MD, Child, Adolescent, and
Adult Psychiatrist;
George Manahan, Parkinson's Advocate and
Patient; and
Kevin O'Connor, Assistant to the General
President for Government Affairs and Political Action,
International Association of Fire Fighters.
On July 13, 2023, the Subcommittee on Health met in open
markup session and forwarded H.R. 3887, as amended, to the full
Committee by a record vote of 15 yeas and 12 nays.
On July 19, 2023, the full Committee on Energy and Commerce
met in open markup session and ordered H.R. 3887, as amended,
favorably reported to the House by a record vote of 27 yeas and
17 nays.
Committee Votes
Clause 3(b) of rule XIII requires the Committee to list the
record votes on the motion to report legislation and amendments
thereto. The following reflects the record votes taken during
the Committee consideration:
Oversight Findings and Recommendations
Pursuant to clause 2(b)(1) of rule X and clause 3(c)(1) of
rule XIII, the Committee held a hearing and made findings that
are reflected in this report.
New Budget Authority, Entitlement Authority, and Tax Expenditures
Pursuant to clause 3(c)(2) of rule XIII, the Committee
finds that H.R. 3887 would result in no new or increased budget
authority, entitlement authority, or tax expenditures or
revenues.
Congressional Budget Office Estimate
Pursuant to clause 3(c)(3) of rule XIII, at the time this
report was filed, the cost estimate prepared by the Director of
the Congressional Budget Office pursuant to section 402 of the
Congressional Budget Act of 1974 was not available.
Federal Mandates Statement
The Committee adopts as its own the estimate of Federal
mandates prepared by the Director of the Congressional Budget
Office pursuant to section 423 of the Unfunded Mandates Reform
Act.
Statement of General Performance Goals and Objectives
Pursuant to clause 3(c)(4) of rule XIII, the general
performance goal or objective of this legislation is to
reauthorize the Children's Hospital Graduate Medical Education
program and prohibit CHGME payments to children's hospitals
furnishing specified procedures or drugs for minors.
Duplication of Federal Programs
Pursuant to clause 3(c)(5) of rule XIII, no provision of
H.R. 3887 is known to be duplicative of another Federal
program, including any program that was included in a report to
Congress pursuant to section 21 of Public Law 111-139 or the
most recent Catalog of Federal Domestic Assistance.
Related Committee and Subcommittee Hearings
Pursuant to clause 3(c)(6) of rule XIII, the following
hearing was used to develop or consider H.R. 3887:
On June 14, 2023, the Subcommittee on Health
held a hearing on H.R. 3887. The title of the hearing
was ``Examining Proposals that Provide Access to Care
for Patients and Support Research for Rare Diseases.''
The Subcommittee received testimony from:
Elizabeth Cherot, MD, MBA,
Senior Vice President and Chief Medical Health
Officer, March of Dimes;
Alexis A. Thompson, MD, MPH,
Chief of Division of Hematology, Elias Schwartz
MD Endowed Chair in Hematology, Children's
Hospital of Philadelphia, Professor of
Pediatrics, University of Pennsylvania Perelman
School of Medicine;
Meredithe McNamara, MD, MS,
FAAP, Assistant Professor, Yale School of
Medicine;
Miriam Grossman, MD, Child,
Adolescent, and Adult Psychiatrist;
George Manahan, Parkinson's
Advocate and Patient; and
Kevin O'Connor, Assistant to the
General President for Government Affairs and
Political Action, International Association of
Fire Fighters.
Committee Cost Estimate
Pursuant to clause 3(d)(1) of rule XIII, the Committee
adopts as its own the cost estimate prepared by the Director of
the Congressional Budget Office pursuant to section 402 of the
Congressional Budget Act of 1974. At the time this report was
filed, the estimate was not available.
Earmarks, Limited Tax Benefits, and Limited Tariff Benefits
Pursuant to clause 9(e), 9(f), and 9(g) of rule XXI, the
Committee finds that H.R. 3887 contains no earmarks, limited
tax benefits, or limited tariff benefits.
Advisory Committee Statement
No advisory committees within the meaning of section 5(b)
of the Federal Advisory Committee Act were created by this
legislation.
Applicability to Legislative Branch
The Committee finds that the legislation does not relate to
the terms and conditions of employment or access to public
services or accommodations within the meaning of section
102(b)(3) of the Congressional Accountability Act.
Section-by-Section Analysis of the Legislation
Section 1. Short title
Section 1 provides a short title of ``Children's Hospital
GME Support Reauthorization Act of 2023.''
Section 2. Program of payments to children's hospitals that operate
graduate medical education programs
Section 2 amends Section 340E of the Public Health Service
Act to reauthorize payments to children's hospitals operating
Graduate Medical Education programs for fiscal years 2024
through 2028 and prohibits payments to children's hospitals
that furnish specified procedures or drugs for minors.
Changes in Existing Law Made by the Bill, as Reported
In compliance with clause 3(e) of rule XIII of the Rules of
the House of Representatives, changes in existing law made by
the bill, as reported, are shown as follows (existing law
proposed to be omitted is enclosed in black brackets, new
matter is printed in italics, and existing law in which no
change is proposed is shown in roman):
PUBLIC HEALTH SERVICE ACT
* * * * * * *
TITLE III--GENERAL POWERS AND DUTIES OF PUBLIC HEALTH SERVICE
* * * * * * *
Part D--Primary Health Care
* * * * * * *
Subpart IX--Support of Graduate Medical Education Programs in
Children's Hospitals
SEC. 340E. PROGRAM OF PAYMENTS TO CHILDREN'S HOSPITALS THAT OPERATE
GRADUATE MEDICAL EDUCATION PROGRAMS.
(a) Payments.--The Secretary shall make two payments under
this section to each children's hospital for each of fiscal
years 2000 through 2005, each of fiscal years 2007 through
2011, each of fiscal years 2014 through 2018, and each of
fiscal years 2019 through [2023] 2028, one for the direct
expenses and the other for indirect expenses associated with
operating approved graduate medical residency training
programs. The Secretary shall promulgate regulations pursuant
to the rulemaking requirements of title 5, United States Code,
which shall govern payments made under this subpart.
(b) Amount of Payments.--
(1) In general.--Subject to paragraphs (2) and (3),
the amounts payable under this section to a children's
hospital for an approved graduate medical residency
training program for a fiscal year are each of the
following amounts:
(A) Direct expense amount.--The amount
determined under subsection (c) for direct
expenses associated with operating approved
graduate medical residency training programs.
(B) Indirect expense amount.--The amount
determined under subsection (d) for indirect
expenses associated with the treatment of more
severely ill patients and the additional costs
relating to teaching residents in such
programs.
(2) Capped amount.--
(A) In general.--The total of the payments
made to children's hospitals under paragraph
(1)(A) or paragraph (1)(B) in a fiscal year
shall not exceed the funds appropriated under
paragraph (1) or (2), respectively, of
subsection (f) for such payments for that
fiscal year.
(B) Pro rata reductions of payments for
direct expenses.--If the Secretary determines
that the amount of funds appropriated under
subsection (f)(1) for a fiscal year is
insufficient to provide the total amount of
payments otherwise due for such periods under
paragraph (1)(A), the Secretary shall reduce
the amounts so payable on a pro rata basis to
reflect such shortfall.
(3) Annual reporting required.--
(A) Reduction in payment for failure to
report.--
(i) In general.--The amount payable
under this section to a children's
hospital for a fiscal year (beginning
with fiscal year 2008 and after taking
into account paragraph (2)) shall be
reduced by 25 percent if the Secretary
determines that--
(I) the hospital has failed
to provide the Secretary, as an
addendum to the hospital's
application under this section
for such fiscal year, the
report required under
subparagraph (B) for the
previous fiscal year; or
(II) such report fails to
provide the information
required under any clause of
such subparagraph.
(ii) Notice and opportunity to
provide missing information.--Before
imposing a reduction under clause (i)
on the basis of a hospital's failure to
provide information described in clause
(i)(II), the Secretary shall provide
notice to the hospital of such failure
and the Secretary's intention to impose
such reduction and shall provide the
hospital with the opportunity to
provide the required information within
a period of 30 days beginning on the
date of such notice. If the hospital
provides such information within such
period, no reduction shall be made
under clause (i) on the basis of the
previous failure to provide such
information.
(B) Annual report.--The report required under
this subparagraph for a children's hospital for
a fiscal year is a report that includes (in a
form and manner specified by the Secretary) the
following information for the residency
academic year completed immediately prior to
such fiscal year:
(i) The types of resident training
programs that the hospital provided for
residents described in subparagraph
(C), such as general pediatrics,
internal medicine/pediatrics, and
pediatric subspecialties, including
both medical subspecialties certified
by the American Board of Pediatrics
(such as pediatric gastroenterology)
and non-medical subspecialties approved
by other medical certification boards
(such as pediatric surgery).
(ii) The number of training positions
for residents described in subparagraph
(C), the number of such positions
recruited to fill, and the number of
such positions filled.
(iii) The types of training that the
hospital provided for residents
described in subparagraph (C) related
to the health care needs of different
populations, such as children who are
underserved for reasons of family
income or geographic location,
including rural and urban areas.
(iv) The changes in residency
training for residents described in
subparagraph (C) which the hospital has
made during such residency academic
year (except that the first report
submitted by the hospital under this
subparagraph shall be for such changes
since the first year in which the
hospital received payment under this
section), including--
(I) changes in curricula,
training experiences, and types
of training programs, and
benefits that have resulted
from such changes; and
(II) changes for purposes of
training the residents in the
measurement and improvement of
the quality and safety of
patient care.
(v) The numbers of residents
described in subparagraph (C) who
completed their residency training at
the end of such residency academic year
and care for children within the
borders of the service area of the
hospital or within the borders of the
State in which the hospital is located.
Such numbers shall be disaggregated
with respect to residents who completed
residencies in general pediatrics or
internal medicine/pediatrics,
subspecialty residencies, and dental
residencies.
(C) Residents.--The residents described in
this subparagraph are those who--
(i) are in full-time equivalent
resident training positions in any
training program sponsored by the
hospital; or
(ii) are in a training program
sponsored by an entity other than the
hospital, but who spend more than 75
percent of their training time at the
hospital.
(D) Report to congress.--Not later than the
end of fiscal year 2018, and the end of fiscal
year 2022, and the end of fiscal year 2028, the
Secretary, acting through the Administrator of
the Health Resources and Services
Administration, shall submit a report to the
Congress--
(i) summarizing the information
submitted in reports to the Secretary
under subparagraph (B);
(ii) describing the results of the
program carried out under this section;
and
(iii) making recommendations for
improvements to the program.
(c) Amount of Payment for Direct Graduate Medical
Education.--
(1) In general.--The amount determined under this
subsection for payments to a children's hospital for
direct graduate expenses relating to approved graduate
medical residency training programs for a fiscal year
is equal to the product of--
(A) the updated per resident amount for
direct graduate medical education, as
determined under paragraph (2); and
(B) the average number of full-time
equivalent residents in the hospital's graduate
approved medical residency training programs
(as determined under section 1886(h)(4) of the
Social Security Act during the fiscal year.
(2) Updated per resident amount for direct graduate
medical education.--The updated per resident amount for
direct graduate medical education for a hospital for a
fiscal year is an amount determined as follows:
(A) Determination of hospital single per
resident amount.--The Secretary shall compute
for each hospital operating an approved
graduate medical education program (regardless
of whether or not it is a children's hospital)
a single per resident amount equal to the
average (weighted by number of full-time
equivalent residents) of the primary care per
resident amount and the non-primary care per
resident amount computed under section
1886(h)(2) of the Social Security Act for cost
reporting periods ending during fiscal year
1997.
(B) Determination of wage and non-wage-
related proportion of the single per resident
amount.--The Secretary shall estimate the
average proportion of the single per resident
amounts computed under subparagraph (A) that is
attributable to wages and wage-related costs.
(C) Standardizing per resident amounts.--The
Secretary shall establish a standardized per
resident amount for each such hospital--
(i) by dividing the single per
resident amount computed under
subparagraph (A) into a wage-related
portion and a non-wage-related portion
by applying the proportion determined
under subparagraph (B);
(ii) by dividing the wage-related
portion by the factor applied under
section 1886(d)(3)(E) of the Social
Security Act for discharges occurring
during fiscal year 1999 for the
hospital's area; and
(iii) by adding the non-wage-related
portion to the amount computed under
clause (ii).
(D) Determination of national average.--The
Secretary shall compute a national average per
resident amount equal to the average of the
standardized per resident amounts computed
under subparagraph (C) for such hospitals, with
the amount for each hospital weighted by the
average number of full-time equivalent
residents at such hospital.
(E) Application to individual hospitals.--The
Secretary shall compute for each such hospital
that is a children's hospital a per resident
amount--
(i) by dividing the national average
per resident amount computed under
subparagraph (D) into a wage-related
portion and a non-wage-related portion
by applying the proportion determined
under subparagraph (B);
(ii) by multiplying the wage-related
Minority Views
H.R. 3887, the Children's Hospital GME Support
Reauthorization Act, would reauthorize the Children's Hospital
Graduate Medical Education (CHGME) program while adding a new
requirement prohibiting children's hospitals that provide
gender-affirming care to people under 18 from receiving
payments under the program. This would endanger a critically
important funding mechanism for pediatric residents by forcing
children's hospitals to choose between funding and providing
evidence-based care. Further, this legislation imposes a
dangerous and unnecessary precedent of inserting the federal
government into private medical decisions that should be made
by patients, their families, and their medical providers.
Gender-affirming care is essential, medically necessary
care that promotes the health and well-being of transgender
people.\1\ This evidence-based care is used to treat gender
dysphoria, which is a serious medical condition characterized
by clinically significant psychological distress associated
with a difference between a person's gender and the sex they
were assigned at birth.\2\ Gender-affirming care makes it both
physically and psychologically possible for transgender people
to live safely and authentically as themselves.
---------------------------------------------------------------------------
\1\Department of Health and Human Services, Substance Use and
Mental Health Services Administration, Moving Beyond Change Efforts:
Evidence and Action to Support and Affirm LGBTQI+ Youth (Mar. 2023)
(PEP22-03-12-001).
\2\American Psychiatric Association, Gender Dysphoria (https://
www.psychiatry.org/patients-families/gender-dysphoria/what-is-gender-
dysphoria) (accessed Jul. 25, 2023).
---------------------------------------------------------------------------
Scientific research over the past 30 years has repeatedly
demonstrated that gender-affirming care improves the health of
transgender people, including the mental health of transgender
youth.\3\ Gender-affirming care also increases life
satisfaction and quality of life.\4\ Additionally, studies have
shown that untreated gender dysphoria can lead to psychological
distress and debilitating depression and often leads to self-
harm, including suicidal ideation and suicide attempts.\5\
---------------------------------------------------------------------------
\3\Amy Green et al., Association of Gender-Affirming Hormone
Therapy With Depression, Thoughts of Suicide, and Attempted Suicide
Among Transgender and Nonbinary Youth, Journal of Adolescent Health
(Apr. 2022).
\4\Diane Chen et al., Psychosocial Functioning in Transgender Youth
after 2 Years of Hormones, The New England Journal of Medicine (January
19, 2023); Christal Achille et al., Longitudinal Impact of Gender-
Affirming Endocrine Intervention on the Mental Health and Well-Being of
Transgender Youths: Preliminary Results (2020).
\5\See note 3.
---------------------------------------------------------------------------
Access to gender-affirming care is critical, medically
necessary, and often lifesaving. Gender-affirming care takes
many forms and is tailored to the age and unique needs of the
individual in consultation with medical doctors, mental health
professionals, and--in the case of youth seeking care--parents.
While not all transgender people access this care, many do over
the course of their lifetimes.
Every major medical association, representing more than 1.3
million U.S. doctors, supports age-appropriate gender-affirming
care for transgender people.\6\ This includes the American
Medical Association,\7\ American Academy of Pediatrics,\8\
American Psychological Association,\9\ American Psychiatric
Association,\10\ American Academy of Child and Adolescent
Psychiatry,\11\ and the Endocrine Society,\12\ among other
organizations.
---------------------------------------------------------------------------
\6\Transgender Legal Defense & Education Fund, Medical Organization
Statements (https://transhealthproject.org/resources/medical-
organization-statements/) (accessed Jul. 25, 2023).
\7\American Medical Association, AMA reinforces opposition to
restrictions on transgender medical care (Jun. 15, 2021).
\8\American Academy of Pediatrics, Policy Statement: Ensuring
Comprehensive Care and Support for Transgender and Gender-Diverse
Children and Adolescents (Oct. 1, 2018).
\9\American Psychology Association, Guidelines for Psychological
Practice with Transgender and Gender Nonconforming People (Dec. 2015).
\10\American Psychiatric Association, Position Statement on
Treatment of Transgender (Trans) and Gender Diverse Youth (Jul. 2020).
\11\American Academy of Child & Adolescent Psychiatry, AACAP
Statement Responding to Efforts to Ban Evidence-Based Care for
Transgender and Gender Diverse Youth (Nov. 8, 2019).
\12\Endocrine Society, Position Statement: Transgender Health (Dec.
16, 2020).
---------------------------------------------------------------------------
H.R. 3887 would prohibit funding through the CHGME program
for any children's hospital that provides gender-affirming
care. Instead of reauthorizing the CHGME program in a
bipartisan manner, as has been done previously, this
legislation politicizes the program and jeopardizes the
training of pediatricians and access to pediatric services
across the country. The CHGME program supports the training of
more than half of all pediatricians and pediatric
subspecialists in the United States.\13\ Given the pediatrician
shortages that already exist, forcing children's hospitals to
choose between critical funding and providing evidence-based
care is particularly ill-advised. Further, this legislation
interferes in medical decisions for transgender youth that
should be determined only by the appropriate providers,
patients, and parents.
---------------------------------------------------------------------------
\13\Health Resources and Services Administration, Children's
Hospitals Graduate Medical Education (CHGME) Payment Program (Mar.
2023).
Frank Pallone, Jr.,
Ranking Member.
[all]